Reduction of rotavirus infection in children receiving bifidobacteria-supplemented formula

P Phuapradit1, W Varavithya, K Vathanophas

  • 1Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Bangkok, Thailand.

Insights

Probiotic-supplemented milk formula may protect children from rotavirus infection. Supplementing with Bifidobacterium Bb12 reduced symptomatic rotavirus infections in young children.

Area of Science:

  • Pediatric Nutrition
  • Microbiology
  • Immunology

Background:

  • Diarrheal diseases are a significant health concern in infants and young children.
  • Rotavirus is a common cause of gastroenteritis in this age group.
  • Probiotics are live microorganisms that may confer health benefits.

Purpose of the Study:

  • To investigate if probiotic-supplemented milk-based formula can protect children from rotavirus infection.
  • To assess the impact of Bifidobacterium Bb12 and Streptococcus thermophilus on rotavirus-specific IgA antibody levels.

Main Methods:

  • A randomized controlled study involving 175 children aged 6-36 months.
  • Children received either standard milk-based formula, formula with Bifidobacterium Bb12, or formula with both Bifidobacterium Bb12 and Streptococcus thermophilus.
  • Salivary rotavirus-specific IgA antibody levels were measured to indicate rotavirus infection.

Main Results:

  • 30.4% of children in the control group showed a significant increase in rotavirus antibody titers, indicating subclinical infection.
  • Children receiving Bifidobacterium Bb12-supplemented formula showed no significant change in antibody titers.
  • The majority of children in the probiotic groups did not exhibit significant changes in antibody levels.

Conclusions:

  • Supplementation with Bifidobacterium Bb12 in milk-based formula may protect children from symptomatic rotavirus infection.
  • Probiotics show potential in preventing rotavirus-related illness in young children.
  • Further research is warranted to confirm these findings and explore mechanisms.

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...